Can the optic nerve be repaired?

Affiliations

¹ Bristol Institute of Clinical Neurosciences, University of Bristol and North Bristol NHS Trust, Level 2, L&R Building, Southmead Hospital, Bristol BS10 5NB, UK.
² Bristol Institute of Clinical Neurosciences, University of Bristol and North Bristol NHS Trust, Level 2, L&R Building, Southmead Hospital, Bristol BS10 5NB, UK. Electronic address: n.j.scolding@bristol.ac.uk.

Comment

Alastair Wilkins et al. Lancet Neurol. 2017 Mar.

. 2017 Mar;16(3):172-173.

doi: 10.1016/S1474-4422(16)30402-1. Epub 2017 Feb 15.

¹ Bristol Institute of Clinical Neurosciences, University of Bristol and North Bristol NHS Trust, Level 2, L&R Building, Southmead Hospital, Bristol BS10 5NB, UK.
² Bristol Institute of Clinical Neurosciences, University of Bristol and North Bristol NHS Trust, Level 2, L&R Building, Southmead Hospital, Bristol BS10 5NB, UK. Electronic address: n.j.scolding@bristol.ac.uk.

No abstract available

Comment on

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial.
Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch L, Frederiksen J, Skeen M, Jaffe GJ, Butzkueven H, Ziemssen F, Massacesi L, Chai Y, Xu L, Freeman S; RENEW Study Investigators. Cadavid D, et al. Lancet Neurol. 2017 Mar;16(3):189-199. doi: 10.1016/S1474-4422(16)30377-5. Epub 2017 Feb 15. Lancet Neurol. 2017. PMID: 28229892 Clinical Trial.